Analysts Set Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) PT at $17.00

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) has received an average recommendation of “Moderate Buy” from the six analysts that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation, three have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $17.00.

A number of research analysts recently weighed in on the company. Stifel Nicolaus reduced their price objective on Senseonics Holdings, Inc. Common Stock from $9.00 to $8.00 and set a “hold” rating for the company in a research report on Monday, May 11th. HC Wainwright reduced their price objective on Senseonics Holdings, Inc. Common Stock from $18.50 to $14.00 and set a “buy” rating for the company in a research report on Tuesday, May 12th. Finally, Weiss Ratings lowered Senseonics Holdings, Inc. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, May 28th.

Insider Buying and Selling

In related news, CEO Timothy T. Goodnow acquired 17,225 shares of Senseonics Holdings, Inc. Common Stock stock in a transaction that occurred on Friday, March 13th. The stock was bought at an average price of $5.79 per share, with a total value of $99,732.75. Following the transaction, the chief executive officer directly owned 651,243 shares in the company, valued at approximately $3,770,696.97. This represents a 2.72% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Douglas A. Roeder acquired 22,686 shares of Senseonics Holdings, Inc. Common Stock stock in a transaction that occurred on Tuesday, May 12th. The shares were bought at an average cost of $5.56 per share, with a total value of $126,134.16. Following the transaction, the director owned 144,635 shares in the company, valued at $804,170.60. This represents a 18.60% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last ninety days, insiders have purchased 57,411 shares of company stock valued at $326,142. 4.70% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Sei Investments Co. purchased a new stake in Senseonics Holdings, Inc. Common Stock during the 2nd quarter valued at $761,000. ExodusPoint Capital Management LP purchased a new stake in Senseonics Holdings, Inc. Common Stock during the 4th quarter valued at $349,000. Jacobs Levy Equity Management Inc. purchased a new stake in Senseonics Holdings, Inc. Common Stock during the 3rd quarter valued at $213,000. Virtu Financial LLC purchased a new stake in Senseonics Holdings, Inc. Common Stock during the 4th quarter valued at $188,000. Finally, Dimensional Fund Advisors LP purchased a new stake in Senseonics Holdings, Inc. Common Stock during the 4th quarter valued at $160,000. Institutional investors own 12.36% of the company’s stock.

Senseonics Holdings, Inc. Common Stock Stock Performance

Shares of NASDAQ:SENS opened at $6.87 on Friday. Senseonics Holdings, Inc. Common Stock has a 52-week low of $4.79 and a 52-week high of $12.58. The company has a market cap of $287.17 million, a price-to-earnings ratio of -3.44 and a beta of 1.04. The stock has a 50 day moving average price of $6.41. The company has a debt-to-equity ratio of 1.05, a current ratio of 3.51 and a quick ratio of 3.19.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) last announced its earnings results on Thursday, May 7th. The company reported ($0.71) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.65) by ($0.06). Senseonics Holdings, Inc. Common Stock had a negative return on equity of 129.97% and a negative net margin of 213.87%.The firm had revenue of $11.71 million during the quarter. On average, equities analysts forecast that Senseonics Holdings, Inc. Common Stock will post -2.38 EPS for the current fiscal year.

About Senseonics Holdings, Inc. Common Stock

Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.

Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.